| Name | Title | Contact Details |
|---|
AdminaHealth is a cloud-based solution provider that develops technology and financial solutions for the benefit and insurance marketplace. The company provides unique operational, reporting and financial solutions to brokers, TPAs, captive managers and the employers and associations they serve. Our goal is to continue to develop solutions that will lower benefit costs while maintaining or improving benefit levels.
DxNA is a St George, UT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Quality Progressions is a Philadelphia, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Blueprint Medicines is developing a new generation of highly selective and potent kinase therapies to dramatically improve the lives of patients with genomically defined diseases. Our approach is rooted in a deep understanding of the genetic blueprint of cancer and other diseases driven by the abnormal activation of kinases. Our ability to identify novel drivers of disease, coupled with our proprietary library of novel and diverse chemical compounds, uniquely enables us to craft kinase therapies against new and difficult-to-drug targets. We are boldly advancing a deep pipeline of highly targeted therapies against previously unaddressed drivers of disease. By focusing on genomically defined subsets of patients, we believe we can identify the people most likely to respond to our therapies, resulting in a more efficient clinical development path with a greater likelihood of success and better outcomes for patients. We see a substantial opportunity in kinase drug discovery and development to deliver breakthrough medicines that allow patients to live longer with better quality of life and prevent recurrences of disease. Kinases are involved in many hallmarks of tumor biology and are proven cancer drug targets. Currently approved drugs focus on less than 5 percent of known kinases, and the function of most kinases is unknown. Led by a team of industry innovators with a track record of bringing life-changing drugs to market, we believe Blueprint Medicines has the experience and expertise to deliver on the tremendous untapped potential of kinase therapies to improve patients’ lives. We don’t think in small steps. We think in giant leaps. We are driven by the pursuit of new ideas, new innovations, and new ways of thinking.
Community Health Resources` (CHR) mission is to help adults, children and families find Real Hope for the challenges of Real Life through an array of community based mental health, substance use, child welfare, supported housing, foster care, prevention and wellness services and integrated care. Our name embodies our commitment to community based care, utilizing all available resources to achieve change, and instill hope for a healthy, happy and productive future. CHR is proud to provide services that achieve Real Quality with Real Results. CHR’s history dates back to the 1960s, and since its creation, has become a trusted community resource and well-respected service provider. We employ over 700 experienced staff members who provided services to more than 18,000 individuals in the past year. We offer effective, accesible and affordable behavioral healthcare through 80 programs and 32 locations. As we anticipate changing needs, we will offer new programs, recruit exceptional staff, collaborate with other providers, and explore new funding sources. The driving force of our growth continues to be meeting the needs of those we serve.